BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8055198)

  • 1. Gold kinetics under long-term treatment with gold(I) disodium thiomalate: a comparison in three different mouse strains.
    Tonn T; Goebel C; Wilhelm M; Gleichmann E
    Br J Rheumatol; 1994 Aug; 33(8):724-30. PubMed ID: 8055198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation.
    Schuhmann D; Kubicka-Muranyi M; Mirtschewa J; Günther J; Kind P; Gleichmann E
    J Immunol; 1990 Oct; 145(7):2132-9. PubMed ID: 2118929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains.
    Pietsch P; Vohr HW; Degitz K; Gleichmann E
    Int Arch Allergy Appl Immunol; 1989; 90(1):47-53. PubMed ID: 2509376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes.
    Goebel C; Kubicka-Muranyi M; Tonn T; Gonzalez J; Gleichmann E
    Arch Toxicol; 1995; 69(7):450-9. PubMed ID: 8526740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the renal toxicity of the antiarthritic drug, gold sodium thiomalate.
    Cheriathundam E; Alvares AP
    J Biochem Toxicol; 1996; 11(4):175-81. PubMed ID: 9062847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain differences in tissue concentrations of mercury in inbred mice treated with mercuric chloride.
    Griem P; Scholz E; Turfeld M; Zander D; Wiesner U; Dunemann L; Gleichmann E
    Toxicol Appl Pharmacol; 1997 May; 144(1):163-70. PubMed ID: 9169080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effect of gold sodium thiomalate on murine acquired immunodeficiency syndrome.
    Yamaguchi K; Ushijima H; Hisano M; Inoue Y; Shimamura T; Hirano T; Müller WE
    Microbiol Immunol; 2001; 45(7):549-55. PubMed ID: 11529562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of stress proteins in mouse peritoneal macrophages by the anti-rheumatic agents gold sodium thiomalate and auranofin.
    Sato H; Yamaguchi M; Shibasaki T; Ishii T; Bannai S
    Biochem Pharmacol; 1995 May; 49(10):1453-7. PubMed ID: 7763288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice.
    Robinson CJ; Balazs T; Egorov IK
    Toxicol Appl Pharmacol; 1986 Nov; 86(2):159-69. PubMed ID: 3097874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of weekly and daily pretreatment with gold sodium thiomalate on adjuvant induced arthritis.
    Cannon GW; Smith CB; Cole BC; Ward JR
    J Rheumatol; 1987 Apr; 14(2):202-8. PubMed ID: 3110416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity parameters in mice of different strains.
    Gol'dberg ED; Masnaya NV; Churin AA
    Bull Exp Biol Med; 2005 Aug; 140(2):219-21. PubMed ID: 16283006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated administration of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):253-6. PubMed ID: 1604050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadmium disposition and metallothionein induction in mice: strain-, sex-, age- and dose-dependent differences.
    Shaikh ZA; Jordan SA; Tewari PC
    Toxicology; 1993 Jun; 80(1):51-70. PubMed ID: 8322372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in cadmium-mediated suppression of lymphocyte proliferation in mice.
    Ohsawa M; Masuko-Sato K; Takahashi K; Otsuka F
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):379-88. PubMed ID: 3487142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of oral and injectable gold compounds.
    Blocka KL; Paulus HE; Furst DE
    Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kojima S
    Toxicology; 1994 May; 90(1-2):39-51. PubMed ID: 8023341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of toxicokinetics on murine mercury-induced autoimmunity.
    Hultman P; Nielsen JB
    Environ Res; 1998 May; 77(2):141-8. PubMed ID: 9600807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subcellular distribution of gold in monkey liver, kidney and spleen, in vivo.
    Sharma RP; McQueen EG
    Clin Exp Pharmacol Physiol; 1979; 6(5):561-7. PubMed ID: 115629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
    Jellum E; Munthe E; Guldal G; Aaseth J
    Ann Rheum Dis; 1980 Apr; 39(2):155-8. PubMed ID: 6770766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.